Chronic fatigue syndrome or myalgic encephalomyelitis.
Burns, Dianne · Nursing standard (Royal College of Nursing (Great Britain) : 1987) · 2012 · DOI
Quick Summary
ME/CFS is a serious illness that affects many body systems, especially the nervous and immune systems, and can impact anyone regardless of age, race, or background. This guideline article helps nurses and healthcare workers recognize and support ME/CFS patients by providing practical knowledge and management strategies. The recommendations can be used by healthcare professionals in different settings to better care for people living with this condition.
Why It Matters
Clear clinical guidelines from nursing authorities improve recognition and appropriate management of ME/CFS across healthcare settings. By standardizing assessment and care approaches, this guideline helps reduce delays in diagnosis and supports better symptom management and patient outcomes.
Observed Findings
ME/CFS affects multiple body systems including nervous and immune systems
The condition occurs across all ages, races, ethnicities, and socioeconomic groups
Healthcare professionals across different settings need standardized knowledge for patient recognition and assessment
Management and rehabilitation principles can be consistently applied by nursing and allied healthcare professionals
Inferred Conclusions
ME/CFS requires multisystem clinical approach focusing on nervous and immune system involvement
Standardized nursing assessment and management protocols are necessary for consistent patient care across healthcare settings
Comprehensive support encompasses recognition, assessment, management, and ongoing patient support strategies
Remaining Questions
What are the specific biological mechanisms underlying nervous and immune system dysfunction in ME/CFS?
Which management and rehabilitation strategies are most effective for different patient subgroups?
How can healthcare systems implement these guidelines to improve diagnostic timeliness and patient outcomes?
What This Study Does Not Prove
This guideline does not present new clinical trial data, identify biological mechanisms, or test specific treatments. It is a consensus document rather than original research and does not establish causation or quantify the effectiveness of individual management strategies.